14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
×
Home
/
Stock Analysis
/
Compare Terminal
/
WORX vs HSTM
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
WORX vs HSTM: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
HSTM Wins Head-to-Head Institutional Verdict (4–1 across 6 Pillars · 10–0 Matrix Metrics)
HSTM Overall Winner
6-Pillar Tally: WORX 1 – 4 HSTM (1 Tie)
Matrix Metrics: WORX 0 – 10 HSTM
As of Nov 16, 2026, HealthStream Inc (HSTM) is the stronger overall head-to-head candidate over SC WORX Corp (WORX) in the Tradestie Institutional Equity Comparison Engine, winning 10–0 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). WORX carries a Unified Composite Score of 34.1/100 (SELL) at $1.15 (N/M Forward P/E, -20.1% operating margin), whereas HSTM carries 55.8/100 (HOLD) at $27.68 (30.1x Forward P/E, 7.8% operating margin).
WORX
NASDAQ
SC WORX Corp
Services-Computer Processing & Data Preparation
Market Cap
$1.7M
TTM Revenue
$2.9M
Forward P/E
N/M
Beta / 30D Vol
23.01β · 208% Vol
Unified Composite Score
34.1 / 100
SELL
Tech 15.0
Fund 31.0
Flow 50.0
Mom 30.0
Weinstein Technical Phase
Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (8.8% over 20 days), RSI 71
RSI-14: 71.4 · SMA20: $0.24 · SMA50: $0.24
HSTM
NASDAQ
Head-to-Head Winner
HealthStream Inc
Services-Computer Programming, Data Processing, Etc.
Market Cap
$855.8M
TTM Revenue
$328M
Forward P/E
30.1x
Beta / 30D Vol
0.39β · 48% Vol
Unified Composite Score
55.8 / 100
HOLD
Tech 45.0
Fund 50.0
Flow 50.0
Mom 55.0
Weinstein Technical Phase
Neutral · Hold
Mixed signals - no dominant trend phase, RSI 28
RSI-14: 28.5 · SMA20: $31.74 · SMA50: $31.07
6-Pillar Scorecard Institutional Category Breakdown (WORX 1 – 4 HSTM)
Columns: Metric · WORX · HSTM
1. Valuation Multiples
HSTM
Forward P/E
N/M
30.1x
Trailing P/E
N/M
40.0x
PEG Ratio
N/M
2.95x
EV / Revenue
0.6x
2.6x
2. Growth & Scale
HSTM
Revenue Growth (YoY)
+3.4%
+8.9%
Earnings Growth (YoY)
+0.0%
-10.0%
TTM Revenue (USD)
$2.9M
$328M
Market Cap
$1.7M
$855.8M
3. Profitability & Quality
HSTM
Gross Margin
44.7%
64.7%
Operating Margin
-20.1%
7.8%
Net Profit Margin
-80.5%
6.2%
Return on Equity (ROE)
-38.1%
5.5%
4. Balance Sheet & Cash Flow
HSTM
Cash Generation (TTM)
-$914,262
$45M EBITDA
Cash Flow Margin
-31.2%
13.6% EBITDA Mgn
Net Cash / Leverage
$77.66 Book/Sh · -38.1% ROE
$13.13 Book/Sh · 5.5% ROE
Dividend Yield
None (0.00%)
0.48%
5. Options & Positioning
Tie
Options Structure Phase
UNCLASSIFIED
UNCLASSIFIED
Current IV / %ile
N/A (N/A)
21.1% (50th %ile)
Put/Call OI Skew
N/A
N/A
OBV Trend / Tech Phase
NEUTRAL · Markup
NEUTRAL · Neutral
6. R&D & Supply-Chain Moat
WORX
OpEx & R&D Intensity
64.8% of Rev ($1.9M)
56.9% of Rev ($187M)
90D R&D Disclosures
0 papers
0 papers
Competitive Moat
Cyclical / Execution-Driven Positioning
Cyclical / Execution-Driven Positioning
Supply-Chain Role
Health Information Services Operator
Health Information Services Operator
Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table
Core Matrix Wins: WORX (0) vs HSTM (10)
Institutional Metric
WORX
HSTM
Criterion
Row Edge
Market Capitalization
Scale
$1.7M
$855.8M
Larger Scale
HSTM
Trailing P/E Ratio
Valuation
N/M
40.0x
Lower Multiple
HSTM
Forward P/E Ratio
Valuation
N/M
30.1x
Lower Multiple
HSTM
Revenue Growth (YoY)
Growth
+3.4%
+8.9%
Higher Growth
HSTM
Operating Margin (TTM)
Profitability
-20.1%
7.8%
Higher Margin
HSTM
Net Profit Margin
Profitability
-80.5%
6.2%
Higher Margin
HSTM
Return on Equity (ROE)
Capital Efficiency
-38.1%
5.5%
Higher ROE
HSTM
52-Week Range Position
Momentum
17% ($0–$6)
51% ($20–$36)
Stronger Trend
HSTM
Beta / 30D Volatility
Risk Regime
23.01β · 208% Vol
0.39β · 48% Vol
Lower Realized Risk
HSTM
Unified Institutional Score
Composite Signal
34.1 / 100 (SELL)
55.8 / 100 (HOLD)
Higher Composite
HSTM
Trailing 12M Revenue (USD)
Operating Scale
$2.9M
$328M
FX-Normalized USD
Scale
Gross Profit Margin (TTM)
Unit Pricing Power
44.7%
64.7%
Higher Margin
Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 0.6x EV/Rev
2.95x PEG · 2.6x EV/Rev
Lower Multiple
Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$914,262 ($77.66 Book/Sh · -38.1% ROE)
$45M EBITDA ($13.13 Book/Sh · 5.5% ROE)
Higher Cash / Net Cash
Solvency
Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)
1M
3M
6M
1Y
1M Horizon
HSTM +0.22 pp
WORX:
-16.67%
·
HSTM:
-16.45%
3M Horizon
WORX +198.06 pp
WORX:
+228.38%
·
HSTM:
+30.32%
6M Horizon
WORX +314.92 pp
WORX:
+327.35%
·
HSTM:
+12.43%
1Y Horizon
WORX +250.12 pp
WORX:
+262.78%
·
HSTM:
+12.66%
Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)
Split-Invariant USD Revenue & Operating Margin (%)
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on WORX vs HSTM. Trailing 12-month operating profitability (WORX -20.1% vs HSTM 7.8%) and valuation multiples (WORX N/M vs HSTM 30.1x Forward P/E) are benchmarked directly in Pillar 4 below.
WORX ADR TTM Benchmark
FX-Normalized USD
TTM Revenue $2.9M
Gross Margin 44.7%
Op. Margin -20.1%
ROE / Fwd P/E -38.1% · N/M
HSTM ADR TTM Benchmark
FX-Normalized USD
TTM Revenue $328M
Gross Margin 64.7%
Op. Margin 7.8%
ROE / Fwd P/E 5.5% · 30.1x
WORX
UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV
N/A
IV Percentile
N/A
Put/Call OI Skew
N/A
IV Regime
Unclassified
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
NEUTRAL
OBV Flow
NEUTRAL
HSTM
UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV
21.1%
IV Percentile
50th %ile
Put/Call OI Skew
N/A
IV Regime
Balanced (25th–60th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
NEUTRAL
OBV Flow
NEUTRAL
WORX Moat Profile
Cyclical / Execution-Driven Positioning
Health Information Services Operator
Competes within the Health Information Services value chain with $1.7M market capitalization and -20.1% operating margin.
OpEx & R&D Reinvestment
64.8% of Rev ($1.9M)
90D Engineering Disclosures
0 Published
HSTM Moat Profile
Cyclical / Execution-Driven Positioning
Health Information Services Operator
Competes within the Health Information Services value chain with $855.8M market capitalization and 7.8% operating margin.
OpEx & R&D Reinvestment
56.9% of Rev ($187M)
90D Engineering Disclosures
0 Published
Investor FAQ WORX vs HSTM Key Questions & Quantitative Answers
Is WORX or HSTM a better stock to buy right now?
As of Nov 16, 2026, HealthStream Inc (HSTM) is the stronger overall head-to-head candidate over SC WORX Corp (WORX) in the Tradestie Institutional Equity Comparison Engine, winning 10–0 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). WORX carries a Unified Composite Score of 34.1/100 (SELL) at $1.15 (N/M Forward P/E, -20.1% operating margin), whereas HSTM carries 55.8/100 (HOLD) at $27.68 (30.1x Forward P/E, 7.8% operating margin). Technically, WORX sits in a Markup phase (RSI 71.4, UNCLASSIFIED options structure) and HSTM sits in a Neutral phase (RSI 28.5, UNCLASSIFIED options structure).
Does WORX or HSTM have stronger revenue and earnings growth?
HSTM leads the Growth & Scale pillar: WORX posts +3.4% YoY revenue growth and +0.0% YoY earnings growth on $2.9M TTM revenue (44.7% gross margin, -20.1% operating margin), compared with HSTM at +8.9% YoY revenue growth and -10.0% YoY earnings growth on $328M TTM revenue (64.7% gross margin, 7.8% operating margin). On trailing 12-month operating scale, WORX generates $2.9M in USD-normalized revenue versus $328M for HSTM. In operating R&D and SG&A reinvestment, WORX deploys 64.8% of Rev ($1.9M) (0 90-day corporate R&D disclosures) versus 56.9% of Rev ($187M) (0 disclosures) for HSTM.
Is WORX or HSTM cheaper on valuation?
HSTM screens cheaper on headline valuation multiples. WORX trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.6x EV/Revenue (-31.2% FCF margin), whereas HSTM trades at 30.1x Forward P/E, 40.0x Trailing P/E, 2.95x PEG, and 2.6x EV/Revenue (13.6% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against WORX (-38.1% ROE) versus HSTM (5.5% ROE) capital efficiency.
How is options market volatility positioned on WORX vs HSTM?
In options market volatility and institutional positioning, WORX carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (23.01β · 208% Vol realized risk). By comparison, HSTM carries 21.1% implied volatility (50th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.39β · 48% Vol realized risk).
SC WORX Corp (WORX) Research Suite
HealthStream Inc (HSTM) Research Suite
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.